A practical reference on albumin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-02 and is reviewed periodically as new material appears.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilized white powder | Supplied as a freeze-dried solid for research use |
| Molecular weight | Approximately 3,647 Da (DAC form) | Lower for the variant lacking the albumin-binding moiety |
| Solubility | Soluble in water and aqueous buffer | Typically dissolved in sterile or bacteriostatic water |
| Typical storage temperature | −20 °C or below | Dry powder, desiccated and protected from light |
| Common analytical method | Reversed-phase HPLC with mass spectrometry | Used for purity estimation and identity confirmation |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Studies showing lack of toxicity of castor oil from the US Public Health Service Castor bean information at Purdue University Plants Poisonous to Livestock – Ricin information at Cornell University Ricin cancer therapy tested at BBC Ricin – Emergency Preparations at CDC Emergency Response Card – Ricin at CDC Overview of all the structural information available in the PDB for UniProt: P02879 (Ricin) at the PDBe-KB.
== History == The first documented synthesis of DBNPA was carried out by Bernhard Conrad Hesse in 1896. DBNPA's practical applications were not explored until 1947, when it started being used as a seed and plant fungicide. Despite this early use, its complete potential as an antibacterial agent was not yet understood. By the early 1970s, DBNPA had gained attention for its effectiveness in controlling microbial contaminations in industrial settings. It started being widely used as a slimicide in papermaking systems, cooling water treatment, and other industries vulnerable to biofouling. DBNPA's demonstrated biocidal efficacy led to its official registration as a pesticide in the US in 1972. Beyond its typical use as a biocide, DBNPA has been investigated for other uses in recent years. Research has investigated its potential as an alternative to antibiotics in bacterial control during ethanol fermentation. DBNPA is often used today as a fast-acting antimicrobial agent to eliminate microbial contamination in manufacturing and industrial processes. Applications needing efficient microbial control with little environmental persistence favour the use of DBNPA due to its quick disintegration in water. Its effectiveness and safety in a variety of industries are still being explored.
At other times - for example, speaking at 2nd annual Memorial for Daniel Pearl, and in print in an article for The Atlantic - he had made comments against the terrorism against Jews in the Middle East. Hitchens stated "But the Jews of the Arab lands were expelled again in revenge for the defeat of Palestinian nationalistic aspirations, in 1947–48, and now the absolute most evil and discredited fabrication of Jew-baiting Christian Europe – The Protocols of the Elders of Zion – is eagerly promulgated in the Hamas charter and on the group's Web site and recycled through a whole nexus of outlets that includes schools as well as state-run television stations". In Slate magazine, Hitchens pondered the notion that, instead of curing antisemitism through the creation of a Jewish state, "Zionism has only replaced and repositioned" it, saying: "there are three groups of 6 million Jews. The first 6 million live in what the Zionist movement used to call Palestine. The second 6 million live in the United States. The third 6 million are distributed mainly among Russia, France, Britain, and Argentina. Only the first group lives daily in range of missiles that can be (and are) launched by people who hate Jews." Hitchens argued that instead of supporting Zionism, Jews should help "secularise and reform their own societies", believing that unless one is religious, "what the hell are you doing in the greater Jerusalem area in the first place?" Hitchens said that the only justification for Zionism given by Jews is a religious one.
Necrotizing fasciitis (NF), also known as flesh-eating disease or flesh-eating bacteria, is an infection that kills the body's soft tissue. It is a serious disease that begins and spreads quickly. It is sometimes incorrectly labeled flesh-eating virus. Symptoms include red or purple or black skin, swelling, severe pain, fever, and vomiting. The most commonly affected areas are the limbs and perineum. Bacterial infection is by far the most common cause of necrotizing fasciitis. Despite being called a "flesh-eating disease", bacteria do not eat human tissue. Rather, they release toxins that cause tissue death. Typically, the infection enters the body through a break in the skin, such as a cut or burn. Risk factors include recent trauma or surgery and a weakened immune system due to diabetes or cancer, obesity, alcoholism, intravenous drug use, and peripheral artery disease. It does not usually spread between people. The disease is classified into four types, depending on the infecting organisms. Medical imaging is often helpful to confirm the diagnosis. Necrotizing fasciitis is treated with surgery to remove the infected tissue, and antibiotics. It is considered a surgical emergency. Delays in surgery are associated with a much higher risk of death. Despite high-quality treatment, the risk of death remains 25–35%.
Sources: en.wikipedia.org
=== Expansion and acquisition === By 1997, Reddy's made the transition from being an API and bulk drug supplier to regulated markets like the US and the UK, and a branded formulations supplier in unregulated markets like India and Russia, into producing generics, by filing an Abbreviated New Drug Application (ANDA) in the USA. The same year, Reddy's out-licensed a molecule for clinical trials to Novo Nordisk, a Danish pharmaceutical company. It strengthened its Indian manufacturing operations by acquiring American Remedies Ltd. in 1999. This acquisition made Reddy's the third largest pharmaceutical company in India, after Ranbaxy and Glaxo (I) Ltd., with a full spectrum of pharmaceutical products, which included bulk drugs, intermediates, finished dosages, chemical synthesis, diagnostics and biotechnology. Reddy's also started exploiting Para 4 filing as a strategy in bringing new drugs to the market at a faster pace. In 1999 it submitted a Para 4 application for omeprazole, the drug that had been the cornerstone of its success in India. In December 2000, Reddy's had undertaken its first commercial launch of a generic product in the US, and its first product with market exclusivity was launched there in August 2001. The same year, it also became the first non-Japanese pharmaceutical company from the Asia-Pacific region to obtain a New York Stock Exchange listing. In 2001 Reddy's became the first Indian company to launch the generic drug, fluoxetine (a generic version of Eli Lilly and Company’s Prozac) with 180-day market exclusivity in the USA.
Treponema pallidum pallidum, which causes syphilis T. p. endemicum, which causes bejel or endemic syphilis T. p. pertenue, which causes yaws The three subspecies causing yaws, bejel, and syphilis are morphologically and serologically indistinguishable. The genomes of three of the T. p. pertenue strains are similar to those of the T. p. pallidum strain, differing by only 0.2%, corresponding to virulence factors. The three subspecies can be distinguished by genetics, using restriction fragment length polymorphism (RFLP), which utilizes techniques such as PCR, restriction digest and gel electrophoresis. Genes tprC, tprI, and the 5' flanking region of tpp15 can be used to differentiate between the three subspecies based on DNA fragment lengths and location of bands in gel electrophoresis. These bacteria were originally classified as members of separate species, but DNA hybridization analysis indicates they are members of the same species. Treponema carateum, the cause of pinta, remains a separate species because no isolate is available for DNA analysis. Disease transmittance in subspecies T. p. endemicum and T. p. pertenue is considered non-venereal. T. p. pallidum is the most invasive pathogenic subspecies, while T. carateum is the least invasive of the species. T. p. endemicum and T. p. pertenue are intermediately invasive.
=== Biological applications === Initially developed for geochemical and related research, NanoSIMS is now utilized by a wide variety of fields, including biology and microbiology. In biomedical research, NanoSIMS is also referred to as multi-isotope imaging mass spectrometry (MIMS). The 50 nm resolution allows unprecedented resolution of cellular and sub-cellular features (as reference, the model organism E. coli is typically 1,000 to 2,000 nm in diameter). The high resolution that it offers allows intracellular measurement of accumulations and fluxes of molecules containing various stable isotopes. NanoSIMS can be used for pure cultures, co-cultures, and mixed community samples. The first use of NanoSIMS in biology was by Peteranderl and Lechene in 2004, who used a prototype of NanoSIMS to examine and measure carbon and nitrogen isotopes of eukaryotic cells. This study was the first time that carbon and nitrogen isotope ratios were directly measured at a sub-cellular scale in a biological sample.
The company reported that it secures raw material for paper cartons in cooperation with the World Wide Fund for Nature (WWF), the Global Forest and Trade Network (GFTN), and FSC, and that it strives to source polyethylene made from sugarcane from sustainable suppliers in Brazil. In 2010, 40 percent of Tetra Pak's carton supply was FSC-certified. Slowly, sectors where glass bottles have been paramount, like the wine and spirits industry, have begun to look at carton containers as a possible packaging product as the carbon footprint of a carton container is said to be about one-tenth of that of an equivalent glass bottle. Tetra Pak's sustainability work has gained recognition from industry and retailers alike. In 2010, it received the Swedish Forest Industries Climate Award for assuming global responsibility for the forests that provide its raw material. The recently introduced Tetra Recart has also been hailed by large retail groups like Sainsbury's as "the 21st Century alternative to canned foods" as the carton's rectangular shape makes transportation, storage, and distribution more efficient, taking up 21 percent less space and weighing two-thirds of a tin can of equivalent volume.
== See also == Stabilizer (chemistry) – Chemical used to prevent degradation wood preservation – Treatment or process aimed at extending the service life of wood structures food preservation – Inhibition of microbial growth in food
Sources: en.wikipedia.org
His season high for strikeouts that year was just seven, achieved in a complete game, four-hit, 4–1 victory over Chicago on September 10. In 30 games (29 starts), he had a 10–14 record, 80 strikeouts, and 91 walks in 189+2⁄3 innings pitched. His 14 losses tied with Bob Friend, Roberts, and Curt Simmons for third in the league (behind Kline's 16 and Johnny Podres's 15), but his 3.42 ERA ranked eighth. Sports Illustrated reported, "Mizell and [Larry] Jackson had impressive ERAs between them but lost more than they won." After working out at the YMCA across from Busch Stadium during the 1958–59 offseason, Mizell showed a stronger fastball in 1959. He did not pitch at the beginning of spring training as he negotiated for a new contract, but he wound up settling for $17,000, his salary each of the previous two seasons. On May 15, he had a season-high 10 strikeouts, allowing just four hits and two unearned runs in an 8–2 victory over the Phillies. He had eight strikeouts in the second game of a doubleheader against Philadelphia on June 7, limiting the Phillies to five hits in a 2–0 shutout victory. In the first half of the season, he enjoyed a 9–3 record and a 3.05 ERA. He was named to both National League All-Star teams in 1959 (in those days, two All-Star games were played in a season). However, he did not appear in either game. The second half of the season saw him post a 4–7 record and a 5.94 ERA. On July 19, 1959, Mizell allowed three runs over seven innings to defeat the Braves, 9–5.
=== Denise Oldroyd === Denise Oldroyd (Fiona Button) is Yasmin's lawyer, and sister of her ex-boyfriend Seb. Denise represents Yasmin following the publication of her father's historic embezzlement from the family publishing company. She also has a brief affair with Eric that begins after he joins her and Yasmin on a cocaine bender. When Hanani Publishing decides to pay off Charles' various legal settlements in exchange for making Yasmin the face of the scandal, Denise encourages Yasmin to go along with the deal to protect the victims of Charles' sexual abuse, but Yasmin decides to fight her father's company in court.
== Mechanism == Rather than being classified as an "autoimmune" disease, SJIA is thought to be an autoinflammatory condition. This is due to the lack of evidence linking any particular antigen-antibody dyad to the pathogenesis or etiology of sJIA. Additionally, sJIA presents with fevers, rash, and multisystem involvement, just like other autoinflammatory illnesses. Autoimmune diseases are adaptive immune system disorders with autoantibodies, while autoinflammatory diseases are caused by innate immune system dysfunction. Several studies show that the innate immune system has a role in sJIA pathogenesis by producing pro-inflammatory cytokines such as interleukin-1, interleukin-6, interleukin-7, interleukin-8, interleukin-18, macrophage migration inhibitory factor, and tumor necrosis factor (TNF). Cytokines have a strong correlation with disease-related systemic characteristics. Elevated interleukin-6 levels are associated with anemia, thrombocytosis, osteoporosis, and delayed growth. Interleukin-1b also contributes significantly to disease etiology.
==== Intramuscular injection ==== In contrast to oral administration, which is associated with very low bioavailability (<10%), the bioavailability of both estradiol and estradiol esters like estradiol valerate is complete (i.e., 100%) via intramuscular injection. In addition, estradiol esters like estradiol cypionate and estradiol valerate when given as an injection of oil solution or microcrystalline aqueous suspension have a relatively long duration due to the formation of an intramuscular depot from which they are slowly released and absorbed. Upon intramuscular injection of estradiol cypionate in an oil solution, the solvent (i.e., oil) is absorbed, and a primary microcrystalline depot is formed within the muscle at the site of injection. In addition, a secondary depot may be formed in adipose tissue. The slow release of estradiol cypionate from the tissue depot is caused by the high lipophilicity of the estradiol ester, which in turn is due to its long fatty acid cypionic acid ester moiety. Estradiol cypionate is formulated for use alone and in combination with testosterone cypionate as an oil solution, and for use in combination with medroxyprogesterone acetate as a microcrystalline aqueous suspension. Aqueous suspensions of steroid esters generally have longer durations by intramuscular injection than oil solutions. A single intramuscular injection of 5 mg estradiol cypionate has been found to result in peak circulating concentrations of 338 pg/mL estradiol and 145 pg/mL estrone, which occurred at about 4 and 5 days post-injection, respectively (see right table).
Sources: en.wikipedia.org
The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.
It has not been approved by major regulatory agencies for any therapeutic indication. Material sold under this name is typically distributed for laboratory research only. Clinical use is not supported by large controlled trials.
Early human studies of the albumin-binding form reported circulation half-lives on the order of several days. The value depends on assay method and study design. Estimates for the form without the binding moiety are considerably shorter.
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.